Biomarker testing has become “increasingly critical” in the care of non-small cell lung cancer.A new investigation into testing rates proved “reassuring” to Kenneth L. Kehl, MD, MPH, assistant ...

Campaign aims to improve lung cancer survival through early detection, education and widespread access to biomarker testing. CHICAGO, Aug. 20, 2025 /PRNewswire/ -- For people with lung cancer, ...

Experts discuss the underutilization of biomarker testing in metastatic lung cancer, emphasizing the need for improved ...

Lung cancer remains the leading cause of cancer deaths in Virginia, according to a new report from the American Lung Association. The 2025 “State of Lung Cancer” report for Virginia found in most ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Dr. Joshua K. Sabari sat down with Terri Conneran at the 2025 World Conference on Lung Cancer for a conversation on the importance of biomarker testing. Dr. Joshua K. Sabari, a thoracic medical ...

Jonathan Thompson, MD, MS, emphasized that comprehensive biomarker testing with next-generation sequencing and PD-L1 analysis—implemented as reflex testing at biopsy—is essential to guide precision ...

David P. Carbone, MD, PhD, director of the thoracic oncology center at The Ohio State University in Columbus, discusses the importance of biomarker testing in both lung cancer overall and non–small ...

The MarketWatch News Department was not involved in the creation of this content. Campaign aims to improve lung cancer survival through early detection, education and widespread access to biomarker ...